Copyright
©The Author(s) 2021.
World J Gastroenterol. Oct 14, 2021; 27(38): 6476-6488
Published online Oct 14, 2021. doi: 10.3748/wjg.v27.i38.6476
Published online Oct 14, 2021. doi: 10.3748/wjg.v27.i38.6476
Predictor | Univariable | Multivariable | ||
OR (95%CI) | P value | Adj. OR (95%CI) | P value | |
Age, per year | 0.98 (0.96-1.00) | 0.10 | - | - |
Male (vs female) | 1.42 (0.72-2.82) | 0.31 | - | - |
CD behavior | ||||
B1 | 1.0 | Not included | ||
B2 | 0.45 (0.22-0.94) | 0.034 | Not included | |
B3 | 0.42 (0.13-1.29) | 0.13 | Not included | |
CD location | ||||
L1: ileal | 1.0 | Not included | ||
L2: colonic | 1.33 (0.54-3.31) | 0.54 | Not included | |
L3: ileocolonic | 0.91 (0.40-2.06) | 0.83 | Not included | |
Ileal location (L1) | 0.94 (0.45-2.00) | 0.88 | Not included | |
Complex disease (B2/B3) | 0.44 (0.22-0.89) | 0.021 | 0.36 (0.16-0.80) | 0.012 |
Active smoker | 0.76 (0.40-1.47) | 0.42 | - | - |
Perianal involvement | 1.14 (0.49-2.65) | 0.77 | Not included | |
Anti-TNF type: infliximab (vs adalimumab) | 1.12 (0.56-2.22) | 0.75 | Not included | |
Baseline immunomodulator | 1.24 (0.47-3.27) | 0.66 | Not included | |
Baseline corticosteroids | 1.10 (0.56-2.18) | 0.78 | Not included | |
Baseline aminosalicylates | 1.16 (0.56-2.40) | 0.69 | Not included | |
Prior anti-TNF | 0.96 (0.37-2.47) | 0.94 | Not included | |
Prior intestinal surgery | 0.71 (0.34-1.48) | 0.36 | - | - |
Disease duration, per loge year | 0.83 (0.65-1.06) | 0.14 | - | - |
Albumin, per g/L | 1.12 (1.03-1.22) | 0.006 | 1.08 (0.98-1.20) | 0.12 |
Hemoglobin, per g/L | 1.01 (0.99-1.04) | 0.32 | - | - |
HCT, per % | 0.91 (0.71-1.16) | 0.44 | - | - |
RCC, per 109/L | 1.07 (0.84-1.36) | 0.60 | Not included | |
MCV, per fL | 1.01 (0.96-1.07) | 0.64 | Not included | |
MCH, per pg/cell | 1.15 (0.99-1.32) | 0.06 | - | - |
MCHC, per mg/L | 1.05 (1.02-1.08) | 0.002 | 1.05 (1.02-1.09) | 0.004 |
Platelets, per 100 × 109/L | 0.63 (0.43-0.93) | 0.020 | - | - |
Neutrophils, per 109/L | 0.91 (0.82-1.00) | 0.06 | - | - |
Lymphocytes, per 109/L | 0.66 (0.46-0.93) | 0.019 | 0.65 (0.41-1.02) | 0.06 |
Monocytes, per 109/L | 0.23 (0.08-0.63) | 0.004 | 0.34 (0.10-1.16) | 0.09 |
Eosinophils, per 109/L | 0.61 (0.08-4.77) | 0.64 | Not included | |
Basophils, per 0.01 × 109/L | 0.92 (0.80-1.06) | 0.24 | - | - |
Bilirubin, per loge µmol/L | 1.38 (0.70-2.72) | 0.36 | - | - |
ALT, per loge IU/L | 1.04 (0.60-1.80) | 0.90 | Not included | |
ALP, per loge IU/L | 0.55 (0.18-1.64) | 0.28 | - | - |
GGT, per loge IU/L | 0.71 (0.46-1.09) | 0.12 | 0.69 (0.43-1.11) | 0.13 |
- Citation: Con D, van Langenberg DR, Vasudevan A. Deep learning vs conventional learning algorithms for clinical prediction in Crohn's disease: A proof-of-concept study. World J Gastroenterol 2021; 27(38): 6476-6488
- URL: https://www.wjgnet.com/1007-9327/full/v27/i38/6476.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i38.6476